Latest News and Press Releases
Want to stay updated on the latest news?
-
Ottawa, April 08, 2025 (GLOBE NEWSWIRE) -- The biologics CDMO secondary packaging market size to record US$ 2.59 billion in 2025 and is projected to grow beyond US$ 5.50 billion by 2034, a study...
-
Dublin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The "Peptide and Oligonucleotide CDMO Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
-
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)" report has been added to ...
-
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Europe Biologics CDMO Market: Focus on Cell Type, Molecule Type, and Country - Analysis and Forecast, 2023-2032" report has been added to ...
-
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Biologics CDMO Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global...
-
Biologics CDMO Market Expected to Reach USD 35.09 Billion with a 10.79% CAGR | Says InsightAce Study
Jersey City, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biologics CDMO Market - (By Cell Type (Mammalian,...
-
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Global Contract Development & Manufacturing Organization (CDMO) Market: Insights & Forecast (2023-2027)" report has been added to ...
-
Dublin, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The "Biologics CDMO Secondary Packaging Market Size and Share Analysis by Type, Primary Package Type - Global Industry Revenue Estimation and Demand...
-
POMEZIA, Italy, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Advent announced today that it is changing its corporate name to Advaxia. The new name reflects the company's evolution, strategic growth and...
-
BRUSSELS, Begium, April 11, 2022 (GLOBE NEWSWIRE) -- Summary: Medi-Tech Insights: The global biologics CDMO market is driven by growing biopharmaceutical end market, rapidly expanding...